RIL
LGND icon

Rothschild Investment LLC’s Ligand Pharmaceuticals LGND Stock Holding History

Rothschild Investment LLC’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$137K Hold
434
– – 0.01% 964
2026
Q1 		$86.6K Buy
434
+1
+0.2% +$198 ﹤0.01% 944
2025
Q4 		$81.9K Hold
433
– – ﹤0.01% 869
2025
Q3 		$76.7K Buy
433
+2
+0.5% +$297 ﹤0.01% 874
2025
Q2 		$49K Hold
431
– – ﹤0.01% 788
2025
Q1 		$45.3K Buy
431
+10
+2% +$1.13K ﹤0.01% 795
2024
Q4 		$45.1K Hold
421
– – ﹤0.01% 802
2024
Q3 		$42.1K Buy
421
+15
+4% +$1.51K ﹤0.01% 823
2024
Q2 		$34.2K Sell
406
-200
-33% -$15.9K ﹤0.01% 845
2024
Q1 		$44.3K Hold
606
– – ﹤0.01% 752
2023
Q4 		$43.3K Buy
+606
New +$35.8K ﹤0.01% 681

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Rothschild Investment LLC's LGND Position: Q2 2026 in Review

Rothschild Investment LLC held its Ligand Pharmaceuticals (LGND) position steady in Q2 2026 at 434 shares worth $137K. The position accounts for 0.01% of the portfolio, ranked #964.

Rothschild Investment LLC first reported a position in LGND in Q4 2023 and has held it in 11 quarters since. 416 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Rothschild Investment LLC held 434 shares of Ligand Pharmaceuticals worth $137K as of Q2 2026.
  • Rothschild Investment LLC left its Ligand Pharmaceuticals share count unchanged in Q2 2026.
  • Ligand Pharmaceuticals made up 0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #964 holding.
  • Rothschild Investment LLC first reported a position in Ligand Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • 416 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.